| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 9 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 9 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 9 |
| 3 | POMALIDOMIDE | 9 |
| 4 | DEXAMETHASONE | 8 |
| 5 | DEXAMETHASONE 1.5 MG | 8 |
| 6 | FLUDARABINE PHOSPHATE | 8 |
| 7 | LENALIDOMIDE | 8 |
| 8 | MELPHALAN | 8 |
| 9 | MELPHALAN HYDROCHLORIDE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BELANTAMAB MAFODOTIN | 7 | 0.0023 |
| 1 | ALDESLEUKIN | 1 | 0.0008 |
| 2 | ETOPOSIDE PHOSPHATE | 1 | 0.0006 |
| 3 | LOMITAPIDE MESYLATE | 2 | 0.0005 |
| 4 | BRODALUMAB | 1 | 0.0005 |
| 5 | BREXUCABTAGENE AUTOLEUCEL | 1 | 0.0005 |
| 6 | MELPHALAN HYDROCHLORIDE | 8 | 0.0003 |
| 7 | PYRIDOSTIGMINE BROMIDE ORAL | 1 | 0.0003 |
| 8 | CARFILZOMIB | 7 | 0.0002 |
| 9 | FLUDARABINE PHOSPHATE | 8 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 11 |
| 1 | Corticosteroid [EPC] | 10 |
| 2 | Thalidomide Analog [EPC] | 10 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 7 |
| 4 | Complement Inhibitor [EPC] | 7 |
| 5 | PCSK9 Inhibitor [EPC] | 7 |
| 6 | Platinum-based Drug [EPC] | 7 |
| 7 | Proteasome Inhibitor [EPC] | 7 |
| 8 | Topoisomerase Inhibitor [EPC] | 7 |
| 9 | Leukocyte Growth Factor [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 7 | 0.0012 |
| 1 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 2 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 3 | PCSK9 Inhibitor [EPC] | 7 | 0.0003 |
| 4 | Complement Inhibitor [EPC] | 7 | 0.0001 |
| 5 | Topoisomerase Inhibitor [EPC] | 7 | 0.0001 |
| 6 | Hemoglobin S Polymerization Inhibitor [EPC] | 2 | 0.0001 |
| 7 | Proteasome Inhibitor [EPC] | 7 | 0.0001 |
| 8 | Alkylating Drug [EPC] | 11 | 0.0000 |
| 9 | Penem Antibacterial [EPC] | 1 | 0.0000 |